Investor Presentaiton

Shareholder Returns: TICS & Clinical Diagnostics Companies Historical Share Price Development (Y vs Y-1) * eurofins Compounded Annual Growth Rates 2 Y 3Y 4 Y 5Y 5Y 2018- 2017- 2016- 2015- Dec-13 Dec-14 Dec-15 Eurofins SGS Intertek BV ALS Quest Diagnostics Sonic Healthcare Charles River Neogen Opko Labcorp 5.5% 18.1% 60.4% 7.9% 51.8% 1.3% -0.3% -6.6% 1.6% -25.9% 19.0% 0.4% -13.8% 0.4% -17.2% -39.0% -25.7% -8.1% 25.3% 6.1% 24.4% 11.6% -3.4% 41.6% 20.0% 26.3% 51.3% 8.5% 14.0% 75.5% 18.4% 0.6% 14.6% Idexx 14.6% 39.4% -1.6% 60.8% FTSE100 14.4% -2.7% -4.9% 14.4% DAX 25.5% 2.7% 9.6% S&P500 29.6% 11.4% -0.7% CAC40 18.0% -0.5% 8.5% 40.4% 7.6% -12.5% 12.1% 6.9% 12.5% -18.3% 25.5% 9.5% 19.4% -6.2% 28.9% 4.9% 9.8% -11.4% 24.2% -20.8% 33.9% 33.4% 19.0% Dec-16 Dec-17 Dec-18 Dec-19 Dec-20 Growth 25.8% 25.3% -35.8% 51.6% 38.9% 113.2% 8.4% 22.6% -13.0% 20.0% 0.7% 25.4% 49.1% -7.5% 21.9% -3.5% 103.4% 0.1% 24.4% -22.3% 30.7% -6.4% 60.2% 15.7% -3.0% 35.4% 4.7% 29.2% 7.2% -15.5% 28.2% 11.6% 19.8% 6.8% -3.3% 30.0% 11.8% -5.2% 43.7% 3.4% 35.0% 63.6% 16.8% 24.6% -7.6% 14.5% 21.5% -7.5% -47.3% -38.6% -51.2% 168.7% 3.8% 2020 2020 2020 2020 45% 11% 14% 16% 39.7% 10% 2% 7% 7% 8% 3% 13% 15% 18.3% 11% -2% 4% 3% 154.9% 19% 11% 12% 21% 67.5% 20% 7% 7% 11% 79.9% 21% 12% 11% 12% 210.8% 49% 32% 35% 25% 87.1% 18% 9% 13% 13% -60.7% 15% -7% -19% -17% 20.3% 64.6% 27% 8% 12% 10% 91.4% -14.3% 585.5% 64% 47% 44% 47% 3.5% -2% -6% -2% 1% 3.5% 27.7% 14% 2% 5% 5% 16.3% 83.8% 22% 12% 14% 13% 26.4% -7.1% 19.7% 8% 1% 3% 4% Source: Bloomberg Based on share prices at close of 31 December of each year Long term (since IPO) Eurofins performance track record (Compounded Annual Growth Rates) 23Y CAGR IPO 27/10/1997 - Eurofins Outperformance Factor 31/12/2020 Eurofins 29.4% FTSE100 1.3% 23.3x DAX 5.6% 5.2x S&P500 6.5% 4.5x CAC40 3.1% 9.6x Source: Bloomberg 101

View entire presentation